A carregar...
Safety of the 9-Valent Human Papillomavirus Vaccine
BACKGROUND: The 9-valent human papillomavirus vaccine (9vHPV) was approved for females and males aged 9 to 26 years in 2014. We analyzed postlicensure surveillance reports to the Vaccine Adverse Event Reporting System (VAERS). METHODS: We searched VAERS data for US reports of adverse events (AEs) af...
Na minha lista:
| Publicado no: | Pediatrics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935554/ https://ncbi.nlm.nih.gov/pubmed/31740500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2019-1791 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|